about
Clinical and biochemical assessment of maintenance treatment in chronic recurrent seborrheic dermatitis: randomized controlled study.Advances in iron chelation: an update.Ciclopirox: an overview.Seborrhoeic dermatitis: current treatment practices.Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties.The safety and efficacy of ciclopirox olamine for the treatment of seborrheic dermatitis.Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review.Naftifine: a review.Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.Scientific Evaluation of Pharmacological Treatment of Osteoarthritis in the Canon of Medicine.Antifungal drugs combinations: a patent review 2000-2015.Topical antifungal-corticosteroid combination therapy for the treatment of superficial mycoses: conclusions of an expert panel meeting.Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study.Inhibitory or scavenging action of ketoconazole and ciclopiroxolamine against reactive oxygen species released by primed inflammatory cells.Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial.Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial.Allergic contact dermatitis from ciclopirox olamine.Oral terbinafine for the treatment of seborrheic dermatitis in adults.Mycosis fungoides responding to systemic itraconazole.Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial.Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis.
P2860
Q33785044-006A8160-F15D-4940-BFA6-7B0313B9B623Q34174307-58C6501E-9C4D-43E7-B968-47CCA5DDEED2Q34368164-7665C299-7DD0-40DC-8EE8-8BDE2D872B3FQ34549487-916D842D-3867-40C4-BDC8-5A213AEE3D95Q35843954-D674BE5C-32DF-4AE4-B901-BC09570BF599Q36082002-E9CAA0AF-D348-42DF-AEC1-DEBAE56CA193Q36179870-9FFAF73C-D563-4416-A3BD-6EB349943F93Q37112042-A5966AF6-AC48-4413-8B3B-272F70E4E1D5Q38395475-70FB6C6E-738B-4CA9-8CB9-7A28F79E0FA4Q38574717-49DB6BFA-F44A-4ADB-812C-B4BEC143FB43Q38712653-1E2D5526-345D-4354-98D4-EC21B1519047Q38750668-C842D2FE-25AC-47B9-B59D-FEB098C27D19Q39357114-88881C79-201C-420D-BBE7-3739C74DFA67Q40134566-AB7BB216-3E2E-48F2-B8C3-631FEA636EDAQ40440181-3DDC2FC3-E4C1-4418-B20D-BEF12BF5A433Q43572241-22ADC075-E29C-4602-A814-4F0EA04DA8C9Q43579517-876C4A04-6EC5-4CD6-94A3-09AF8500F5E0Q44230170-8685C754-E9DB-4B1F-B068-C1C1CE00B9FCQ44563455-DA40015D-DFE5-4351-AD55-6D409B76411DQ44991069-C2449697-21BC-4214-A3BE-F6E9AC69EDA2Q48182426-920349E1-C062-44B7-9400-C9D2F345DD4CQ51735192-BD6F06EF-8B51-4BA8-B6C9-B10084BE831B
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Anti-inflammatory activity of antifungal preparations.
@en
Anti-inflammatory activity of antifungal preparations.
@nl
type
label
Anti-inflammatory activity of antifungal preparations.
@en
Anti-inflammatory activity of antifungal preparations.
@nl
prefLabel
Anti-inflammatory activity of antifungal preparations.
@en
Anti-inflammatory activity of antifungal preparations.
@nl
P2093
P1476
Anti-inflammatory activity of antifungal preparations.
@en
P2093
P304
P356
10.1046/J.1365-4362.1997.00309.X
P577
1997-10-01T00:00:00Z